Abstract
Ligand-directed signaling, biased agonism, and functional selectivity are terms that describe the propensity of a ligand to drive signaling toward one GPCR pathway over another. Most of the early examples demonstrated to date examine the divergence between GPCR signaling to G protein coupling and βarrestin2 recruitment. As biased agonists begin to become available based on cell-based screening criteria, a need arises to determine if G protein signaling biases will be maintained in the endogenous setting, wherein receptors are functioning to control relevant biological responses. This report presents our method and offers tips for evaluating G protein signaling in endogenous tissues. Predominately, brain tissues are discussed here; optimization points that can be applied to any tissues are highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rajagopal S, Rajagopal K, Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9:373–386
Wisler J, Xiao K, Thomsen A, Lefkowitz R (2014) Recent developments in biased agonism. Curr Opin Cell Biol 27:18
Zhou L, Lovell KM, Frankowski KJ, Slauson SR, Phillips AM, Streicher JM, Stahl E, Schmid CL, Hodder P, Madoux F (2013) Development of functionally selective, small molecule agonists at kappa opioid receptors. J Biol Chem 288:36703–36716
Rahmeh R, Damian M, Cottet M, Orcel H, Mendre C, Durroux T, Sharma KS, Durand G, Pucci B, Trinquet E (2012) Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy. Proc Natl Acad Sci 109:6733–6738
Rivero G, Llorente J, McPherson J, Cooke A, Mundell SJ, McArdle CA, Rosethorne EM, Charlton SJ, Krasel C, Bailey CP (2012) Endomorphin-2: a biased agonist at the μ-opioid receptor. Mol Pharmacol 82:178–188
Hurowitz EH, Melnyk JM, Chen Y-J, Kouros-Mehr H, Simon MI, Shizuya H (2000) Genomic characterization of the human heterotrimeric G protein α, β, and γ subunit genes. DNA Res 7:111–120
Baltoumas FA, Theodoropoulou MC, Hamodrakas SJ (2013) Interactions of the α-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials. J Struct Biol 182:209–218
Schmid CL, Streicher JM, Groer CE, Munro TA, Zhou L, Bohn LM (2013) Functional selectivity of 6′-guanidinonaltrindole (6′-GNTI) at κ-opioid receptors in striatal neurons. J Biol Chem 288:22387–22398
Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin F-T (1999) Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 286:2495–2498
Dennis I, Whalley BJ, Stephens GJ (2008) Effects of Δ9‐tetrahydrocannabivarin on [35S] GTPγS binding in mouse brain cerebellum and piriform cortex membranes. Br J Pharmacol 154:1349–1358
Hungund B, Vinod K, Kassir S, Basavarajappa B, Yalamanchili R, Cooper T, Mann J, Arango V (2004) Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9:184–190
Jin LQ, Wang HY, Friedman E (2001) Stimulated D1 dopamine receptors couple to multiple Gα proteins in different brain regions. J Neurochem 78:981–990
Márki Á, Monory K, Ötvös F, Tóth G, Krassnig R, Schmidhammer H, Traynor JR, Roques BP, Maldonado R, Borsodi A (1999) μ-Opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S] GTPγS binding assays. Eur J Pharmacol 383:209–214
Panchalingam S, Undie AS (2000) Optimized binding of [35S] GTPγS to Gq-like proteins stimulated with dopamine D1-like receptor agonists. Neurochem Res 25:759–767
Szekeres PG, Traynor JR (1997) Delta opioid modulation of the binding of guanosine-5′-O-(3-[35S] thio) triphosphate to NG108–15 cell membranes: characterization of agonist and inverse agonist effects. J Pharmacol Exp Ther 283:1276–1284
Odagaki Y, Toyoshima R (2006) Dopamine D 2 receptor-mediated G protein activation assessed by agonist-stimulated [35S] guanosine 5′-O-(γ-thiotriphosphate) binding in rat striatal membranes. Prog Neuro-Psychopharmacol Biol Psychiatr 30:1304–1312
Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li J-G, Cowan A, Liu-Chen L-Y (2005) Comparison of pharmacological activities of three distinct κ ligands (salvinorin A, TRK-820 and 3FLB) on κ opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. J Pharmacol Exp Ther 312:220–230
Savinainen JR, Järvinen T, Laine K, Laitinen JT (2001) Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor‐dependent G‐protein activation in rat cerebellar membranes. Br J Pharmacol 134:664–672
Sim-Selley L, Daunais J, Porrino L, Childers S (1999) Mu and kappa 1 opioid-stimulated [35S] guanylyl-5′-O-(γ-THIO)-triphosphate binding in cynomolgus monkey brain. Neuroscience 94:651–662
Rinken A, Finnman U-B, Fuxe K (1999) Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5′-(γ-thiotriphosphate)([35S] GTPγS) binding in rat striatal membranes. Biochem Pharmacol 57:155–162
Albrecht E, Samovilova NN, Oswald S, Baeger I, Berger H (1998) Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5′-O-(γ-thio)-triphosphate binding in rat brain membranes. J Pharmacol Exp Ther 286:896–902
Zhu J, Luo L-Y, Li J-G, Chen C, Liu-Chen L-Y (1997) Activation of the cloned human kappa opioid receptor by agonists enhances [35S] GTPγS binding to membranes: determination of potencies and efficacies of ligands. J Pharmacol Exp Ther 282:676–684
Selley DE, Sim LJ, Xiao R, Liu Q, Childers SR (1997) μ-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 51:87–96
Traynor JR, Nahorski SR (1995) Modulation by mu-opioid agonists of guanosine-5′-O-(3-[35S] thio) triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848–854
Sim LJ, Selley DE, Childers SR (1995) In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S] thio]-triphosphate binding. Proc Natl Acad Sci 92:7242–7246
Wettschureck N, Offermanns S (2005) Mammalian G proteins and their cell type specific functions. Physiol Rev 85:1159–1204
Hinton DR, Blanks JC, Fong H, Casey PJ, Hildebrandt E, Simons MI (1990) Novel localization of a G protein, Gz-alpha, in neurons of brain and retina. J Neurosci 10:2763–2770
Matesic D, Manning D, Wolfe B, Luthin G (1989) Pharmacological and biochemical characterization of complexes of muscarinic acetylcholine receptor and guanine nucleotide-binding protein. J Biol Chem 264:21638–21645
Law SF, Manning D, Reisine T (1991) Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J Biol Chem 266:17885–17897
Law S, Reisine T (1992) Agonist binding to rat brain somatostatin receptors alters the interaction of the receptors with guanine nucleotide-binding regulatory proteins. Mol Pharmacol 42:398–402
Chalecka‐Franaszek E, Weems HB, Crowder AT, Cox BM, Côté TE (2000) Immunoprecipitation of high‐affinity, guanine nucleotide‐sensitive, solubilized μ‐opioid receptors from rat brain. J Neurochem 74:1068–1078
Sidhu A, Kimura K, Uh M, White BH, Patel S (1998) Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz. J Neurochem 70:2459–2467
Georgoussi Z, Milligan G, Zioudrou C (1995) Immunoprecipitation of opioid receptor-Go-protein complexes using specific GTP-binding-protein antisera. Biochem J 306:71–75
Acknowledgement
NIH/NIDA grants DA0031927, DA033073, DA009158 fund G protein signaling projects in our laboratory.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Bohn, L.M., Zhou, L., Ho, JH. (2015). Approaches to Assess Functional Selectivity in GPCRs: Evaluating G Protein Signaling in an Endogenous Environment. In: Filizola, M. (eds) G Protein-Coupled Receptors in Drug Discovery. Methods in Molecular Biology, vol 1335. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2914-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2914-6_12
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2913-9
Online ISBN: 978-1-4939-2914-6
eBook Packages: Springer Protocols